Core Technology PICT


Bottlenecks in Peptide Drug Development

It has a short half-life and is not easily administered orally.

1. Prone to enzymatic degradation, oxidation, and hydrolysis; exhibits poor stability.
2. High renal clearance
3. Prone to aggregation and precipitation
4. Low cell membrane permeability

  • Peptide Synthesis Chemistry
  • Peptide Medicinal Chemistry
  • Peptide formulations and delivery optimization
  • Structural biology, computational chemistry
Core Technology PICT

1. Cyclic structure

2. Amino-terminal methylation

3. Introduction of non-natural or D‑configured amino acids

4. Fatty acidylation, PEGylation, and fusion proteins

5. Optimization of drug delivery systems: liposomes, nanoparticles, microspheres, etc.

There is a scarcity of sources for peptide-based bioactive molecules.

1. Endogenous peptides/natural bioactive peptides
2. Chemically Synthesized Peptides
3. Phage-display peptide library/mRNA-display peptide library/DNA-encoded peptide library/virtual peptide library

Core Technology PICT
  • Limited quantity; difficult to isolate, identify, and synthesize.
  • Small storage capacity and insufficient diversity; high costs and time-consuming.
  • Compound library; large library capacity; screening methods with limited target scope; high false-positive and false-negative rates.

PICT technology

Comparative Analysis of Similar Technologies

PepLib (China)

PepLib (China)

PICT

1、Library size: 0.5x109

2、Quantitative peptide determination with fewer false positives/negatives

3、One peptide per well, suitable for HTS

4、Active molecular sequences are known

5、Suitable for a wide range of targets

6、Versatile screening methods: suitable for molecular, cellular, and animal-level screening

Bicycle (UK)

Bicycle (UK)

Phage Display

1、Library size: 10⁹-¹¹

2、Variable peptide quantities with higher chance of false positives/negatives

3、Active molecular sequences require gene sequencing

4、Limited to water-soluble targets: generally, not suitable for membrane protein targets

5、Screening limited to molecular-level binding assays

6、Double-loop structures with good stability

PeptiDream (Japan)

PeptiDream (Japan)

mRNA Display

1、Library size: 10⁹-¹¹

2、Variable peptide quantities with higher false positives/negatives

3、Mixture format, not suitable for HTS

4、Active molecular sequences require gene sequencing

5、Screening limited to molecular-level binding assays

6、Suitable only for water-soluble targets: generally, not suitable for membrane proteins

7、Can incorporate non-natural amino acids

The process of discovering bioactive molecules using a comprehensive peptide library.

Image Name

The Process of Innovative Peptide Drug Development

Image Name